A series of dinuclear organophosphorus-bridged complexes of the general formula {(LVO(μ-O(2)PRR')}(2) [L = η(5)-cyclopentadienyltris(diethylphosphito-κ(1)P) cobaltate(III)] has been synthesized as a structural model for the industrially used vanadium phosphate oxidation catalysts. These dimeric species contain two vanadium centers in a VO(6) environment bridged by O-P-O units. These complexes have been characterized via spectral and magnetic analyses. Structural parameters have been analyzed through X-ray diffraction. The dimers generally exist in either a cis/cis-anti or retracted chair conformation in the solid state. The syntheses, structural, spectral, and magnetic data are presented and discussed here.
A series of dinuclear organophosphorus‐bridged vanadium(IV) complexes with the Kläui ligand, [CpPOMeCo]–, have been synthesized to model the catalytic activity of industrially used vanadium phosphate oxidation catalysts. Dimeric species of the general formula [(CpPOMeCo)V(O)(μ‐O2PR′R″)]2 (R′,R″ = H, OH, Me, Ph, or 4‐OPh‐NO2), [(CpPOMeCo)V(O)]2(μ‐oxalate), and [(CpPOMeCo)V(Cl)]2(μ‐oxalate) are reported. These complexes have been characterized via spectral and magnetic analyses. The synthesis, characterization, and X‐ray structures of the mononuclear vanadium(IV) complexes (CpPOMeCo)V(O)Cl(OH2) and(CpPOMeCo)V(O)(acac) are also presented here. [CpPOMeCo]–= η5‐cyclopentadienyltris(dimethylphosphito‐κ1P)cobaltate(III); acac = acetylacetonate.
The title compound, C21H27NO2, exhibits hydrogen bonding between the phenolic H atom and the heterocyclic N atom. The absolute configuration of the molecule is known from the synthetic procedure.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.